SB 223 – Utah

Status: Inactive / Dead
Year Introduced: 2019
Link: https://le.utah.gov/~2019/bills/static/SB0223.html

Pharmaceutical Entity Transparency Act: amends provisions related to the information an insurer and health benefit plan must provide to an enrollee or prospective enrollee, including information regarding formulary changes; requires a pharmacy benefit manager to be licensed by the Insurance Department to conduct business in the state; requires reports by certain entities to the Insurance Department regarding the impact of costs of prescription drugs, including information on the costliest drugs and drugs with high increases in spending; requires a pharmacy benefit manager to report certain information to a health insurer or plan sponsor regarding drug utilization payments; requires pharmaceutical manufacturers to report certain information related to prescription drug price increases and introduction; amends provisions related to a pharmacist substituting a prescription drug, etc.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found